Braxia Scientific Corp. (BRAX.CN) Research

Braxia Scientific Corp. is a medical research enterprise that runs clinics specializing in ketamine-based treatments for individuals facing depression and related conditions. The company further operates a network of multidisciplinary clinics dedicated to addressing a wide spectrum of mental health disorders. Beyond its clinical services, Braxia is actively engaged in research and development, striving to discover and commercialize novel pharmaceutical compounds and advanced delivery systems. Utilizing its intellectual property development platform, it focuses on the creation and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products. The firm's corporate headquarters are located in Toronto, Ontario.

Market snapshot

Symbol
BRAX.CN
Price
$0.01
Day change
0.00%
Market cap
$1.4M
P/E ratio
-0.09x
52-week range
0.005-0.01
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Delta 9 Cannabis Inc. (DN.TO)
  • Entourage Health Corp. (ENTG.V)
  • HAVN Life Sciences Inc. (HAVN.CN)
  • New Leaf Ventures Inc (NLV.CN)
  • Origin Therapeutics Holdings Inc. (ORIG.CN)
  • PsyBio Therapeutics Corp. (PSYB.V)
  • The Hash Corporation (REZN.CN)
  • RepliCel Life Sciences Inc. (RP.V)

Open Braxia Scientific Corp. (BRAX.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.